HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC

Der Urologe- Germany

doi 10.1007/s00120-004-0603-9

Full Text

Abstract

Available in

Categories

Urology

Date

Authors

Publisher

Springer Nature


Related search